← Evidence map

ArticleOncotarget2020

NRXN1 as a novel potential target of antibody-drug conjugates for small cell lung cancer.

Takuma Yotsumoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

12 papers cite it

2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33062195